Nicholas Rouillard is a seasoned professional in bioinformatics and genomics with a robust background in the biotech industry. Currently serving as a Sr. Principal Scientist at Eli Lilly and Company since June 2025, Nicholas previously held various positions at Affini-T Therapeutics from November 2021 to February 2025, where roles included Sr. Scientist I and Scientist II. Prior experience includes a tenure at bluebird bio, where Nicholas advanced from Associate Scientist II to Senior Associate Scientist II between April 2018 and November 2021. Nicholas began a career in academic research at New York University as a Genomics Core Technician and developed foundational expertise in microbiological and molecular evolution while working with Dr. Jeffery Foster and Dr. Vaughn Cooper at the University of New Hampshire as an Undergraduate Research Assistant. Education includes a Bachelor of Science in Genetics from the University of New Hampshire, earned in 2016.
This person is not in the org chart
This person is not in any teams
This person is not in any offices